# Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?

> **NCT06130241** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 30 (estimated)

## Conditions studied

- Sentinel Lymph Node

## Interventions

- **PROCEDURE:** sentinle lymphnode biopsy

## Key facts

- **NCT ID:** NCT06130241
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-30
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06130241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06130241, "Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06130241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*